![Joseph J. Hlavka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph J. Hlavka
Corporate Officer/Principal at Tetragenex Pharmaceuticals, Inc.
Profile
Joseph J.
Hlavka is currently the Director of Tetracycline Design & Synthesis at Tetragenex Pharmaceuticals, Inc. He obtained a doctorate degree from the Massachusetts Institute of Technology in 1957.
Joseph J. Hlavka active positions
Companies | Position | Start |
---|---|---|
Tetragenex Pharmaceuticals, Inc.
![]() Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Corporate Officer/Principal | 04/02/2010 |
Training of Joseph J. Hlavka
Massachusetts Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Tetragenex Pharmaceuticals, Inc.
![]() Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
- Stock Market
- Insiders
- Joseph J. Hlavka